APO Research

APO RESEARCH · REPORT

Telepsychiatry

Telepsychiatry is a branch of telemedicine defined by the electronic delivery of psychiatric services to patients. This typically includes providing psychiatric assessments, therapeutic services, and medication management via telecommunication technology, most commonly videoconferencing.

Product & engineering

Understand the product.

Telepsychiatry is a branch of telemedicine defined by the electronic delivery of psychiatric services to patients. This typically includes providing psychiatric assessments, therapeutic services, and medication management via telecommunication technology, most commonly videoconferencing.

Selected research

Market Outlook & Growth Opportunities

Global Telepsychiatry Market Outlook and Growth Opportunities 2026

Market perspective

Telepsychiatry is a branch of telemedicine defined by the electronic delivery of psychiatric services to patients. This typically includes providing psychiatric assessments, therapeutic services, and medication management via telecommunication technology, most commonly videoconferencing.

Global Telepsychiatry key players include InSight Telepsychiatry, American Telepsychiatrists, Iris Telehealth, JSA Health, Advanced Telemed Services, etc. Global top five manufacturers hold a share over 55%.

North America is the largest market, with a share over 80%, followed by Asia and Europe, both have a share over 10%.

Read the full market overview

In terms of application, the largest application is Adult, followed by Teenagers, Geriatric Populations, etc.

This report provides an overview of the global Telepsychiatry market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Telepsychiatry and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Telepsychiatry revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Telepsychiatry market.

Telepsychiatry Segment by Company

InSight Telepsychiatry

American Telepsychiatrists

Iris Telehealth

JSA Health

Advanced Telemed Services

FasPsych

Genoa

Encounter Telehealth

Arcadian Telepsychiatry

InnovaTel

Telepsychiatry Segment by Type

Routine Telepsychiatry

Forensic Telepsychiatry

Crisis Telepsychiatry

In-Home Telepsychiatry

Telepsychiatry Segment by End User

Adults

Teenagers

Geriatric Populations

Telepsychiatry Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Telepsychiatry status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Telepsychiatry key companies, revenue, market share, and recent developments.

3. To split the Telepsychiatry breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Telepsychiatry market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Telepsychiatry significant trends, drivers, influence factors in global and regions.

6. To analyze Telepsychiatry competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Telepsychiatry market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Telepsychiatry and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Telepsychiatry.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Telepsychiatry industry.

Chapter 3: Detailed analysis of Telepsychiatry company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Telepsychiatry in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Telepsychiatry in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Telepsychiatry Industry Trends Table 2. Telepsychiatry Industry Drivers Table 3. Telepsychiatry Industry Opportunities and Challenges Table 4. Telepsychiatry Industry Restraints Table 5. Global Telepsychiatry Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Telepsychiatry Revenue Share by Company (2021-2026) Table 7. Global Telepsychiatry Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Telepsychiatry Key Company Manufacturing Base & Headquarters Table 9. Global Telepsychiatry Company, Product Type & Application Table 10. Global Telepsychiatry Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Telepsychiatry by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Routine Telepsychiatry Table 15. Significant Companies of Forensic Telepsychiatry Table 16. Significant Companies of Crisis Telepsychiatry Table 17. Significant Companies of In-Home Telepsychiatry Table 18. Global Telepsychiatry Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Telepsychiatry Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Telepsychiatry Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Telepsychiatry Sales Value Share by Type (2021-2026) Table 22. Global Telepsychiatry Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Adults Table 24. Significant Companies of Teenagers Table 25. Significant Companies of Geriatric Populations Table 26. Global Telepsychiatry Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Telepsychiatry Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Telepsychiatry Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Telepsychiatry Sales Value Share by Application (2021-2026) Table 30. Global Telepsychiatry Sales Value Share by Application (2027-2032) Table 31. Global Telepsychiatry Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Telepsychiatry Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Telepsychiatry Sales Value Share by Region (2021-2026) Table 34. Global Telepsychiatry Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Telepsychiatry Sales Value Share by Region (2027-2032) Table 36. Global Telepsychiatry Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Telepsychiatry Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Telepsychiatry Sales Value Market Share by Country (2021-2026) Table 39. Global Telepsychiatry Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Telepsychiatry Sales Value Market Share by Country (2027-2032) Table 41. InSight Telepsychiatry Company Information Table 42. InSight Telepsychiatry Business Overview Table 43. InSight Telepsychiatry Telepsychiatry Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. InSight Telepsychiatry Telepsychiatry Product Portfolio Table 45. InSight Telepsychiatry Recent Development Table 46. American Telepsychiatrists Company Information Table 47. American Telepsychiatrists Business Overview Table 48. American Telepsychiatrists Telepsychiatry Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. American Telepsychiatrists Telepsychiatry Product Portfolio Table 50. American Telepsychiatrists Recent Development Table 51. Iris Telehealth Company Information Table 52. Iris Telehealth Business Overview Table 53. Iris Telehealth Telepsychiatry Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Iris Telehealth Telepsychiatry Product Portfolio Table 55. Iris Telehealth Recent Development Table 56. JSA Health Company Information Table 57. JSA Health Business Overview Table 58. JSA Health Telepsychiatry Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. JSA Health Telepsychiatry Product Portfolio Table 60. JSA Health Recent Development Table 61. Advanced Telemed Services Company Information Table 62. Advanced Telemed Services Business Overview Table 63. Advanced Telemed Services Telepsychiatry Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Advanced Telemed Services Telepsychiatry Product Portfolio Table 65. Advanced Telemed Services Recent Development Table 66. FasPsych Company Information Table 67. FasPsych Business Overview Table 68. FasPsych Telepsychiatry Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. FasPsych Telepsychiatry Product Portfolio Table 70. FasPsych Recent Development Table 71. Genoa Company Information Table 72. Genoa Business Overview Table 73. Genoa Telepsychiatry Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Genoa Telepsychiatry Product Portfolio Table 75. Genoa Recent Development Table 76. Encounter Telehealth Company Information Table 77. Encounter Telehealth Business Overview Table 78. Encounter Telehealth Telepsychiatry Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Encounter Telehealth Telepsychiatry Product Portfolio Table 80. Encounter Telehealth Recent Development Table 81. Arcadian Telepsychiatry Company Information Table 82. Arcadian Telepsychiatry Business Overview Table 83. Arcadian Telepsychiatry Telepsychiatry Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Arcadian Telepsychiatry Telepsychiatry Product Portfolio Table 85. Arcadian Telepsychiatry Recent Development Table 86. InnovaTel Company Information Table 87. InnovaTel Business Overview Table 88. InnovaTel Telepsychiatry Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. InnovaTel Telepsychiatry Product Portfolio Table 90. InnovaTel Recent Development Table 91. Research Programs/Design for This Report Table 92. Authors List of This Report Table 93. Secondary Sources Table 94. Primary Sources List of Figures Figure 1. Telepsychiatry Product Image Figure 2. Global Telepsychiatry Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Telepsychiatry Market Size (2021-2032) & (US$ Million) Figure 4. Global Telepsychiatry Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Routine Telepsychiatry Image Figure 8. Forensic Telepsychiatry Image Figure 9. Crisis Telepsychiatry Image Figure 10. In-Home Telepsychiatry Image Figure 11. Global Telepsychiatry Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Telepsychiatry Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Telepsychiatry Sales Value Share by Type (2021-2032) Figure 14. Adults Image Figure 15. Teenagers Image Figure 16. Geriatric Populations Image Figure 17. Global Telepsychiatry Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Telepsychiatry Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Telepsychiatry Sales Value Share by Application (2021-2032) Figure 20. Global Telepsychiatry Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Telepsychiatry Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Telepsychiatry Sales Value (2021-2032) & (US$ Million) Figure 23. North America Telepsychiatry Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Telepsychiatry Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Telepsychiatry Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Telepsychiatry Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Telepsychiatry Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Telepsychiatry Sales Value (2021-2032) & (US$ Million) Figure 29. South America Telepsychiatry Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Telepsychiatry Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Telepsychiatry Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Telepsychiatry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Telepsychiatry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Telepsychiatry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Telepsychiatry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Telepsychiatry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Telepsychiatry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Telepsychiatry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Telepsychiatry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Telepsychiatry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Telepsychiatry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Telepsychiatry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Telepsychiatry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Telepsychiatry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Telepsychiatry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Telepsychiatry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Telepsychiatry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Telepsychiatry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Telepsychiatry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Telepsychiatry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Telepsychiatry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Telepsychiatry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Telepsychiatry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Telepsychiatry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Telepsychiatry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Telepsychiatry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Telepsychiatry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Telepsychiatry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Telepsychiatry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Telepsychiatry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Telepsychiatry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Telepsychiatry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Telepsychiatry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Telepsychiatry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Telepsychiatry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Telepsychiatry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Telepsychiatry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Telepsychiatry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Telepsychiatry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Telepsychiatry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Telepsychiatry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Telepsychiatry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Telepsychiatry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Telepsychiatry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Telepsychiatry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Telepsychiatry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Telepsychiatry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Telepsychiatry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Telepsychiatry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Telepsychiatry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Telepsychiatry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Telepsychiatry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Telepsychiatry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Telepsychiatry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Telepsychiatry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Telepsychiatry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Telepsychiatry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Telepsychiatry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Telepsychiatry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Telepsychiatry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Telepsychiatry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Telepsychiatry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Telepsychiatry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Telepsychiatry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Telepsychiatry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Telepsychiatry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Telepsychiatry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Telepsychiatry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Telepsychiatry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Telepsychiatry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Telepsychiatry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Telepsychiatry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Telepsychiatry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Telepsychiatry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Telepsychiatry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Telepsychiatry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Telepsychiatry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Telepsychiatry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Telepsychiatry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Telepsychiatry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Telepsychiatry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Telepsychiatry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Telepsychiatry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Telepsychiatry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Telepsychiatry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Routine Telepsychiatry
  • Forensic Telepsychiatry
  • Crisis Telepsychiatry
  • In-Home Telepsychiatry
Applications
  • Adults
  • Teenagers
  • Geriatric Populations
Companies covered
  • InSight Telepsychiatry
  • American Telepsychiatrists
  • Iris Telehealth
  • JSA Health
  • Advanced Telemed Services
  • FasPsych
  • Genoa
  • Encounter Telehealth
  • Arcadian Telepsychiatry
  • InnovaTel

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Telepsychiatry Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Telepsychiatry Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Telepsychiatry Market Dynamics
  1. 2.1 Telepsychiatry Industry Trends
  2. 2.2 Telepsychiatry Industry Drivers
  3. 2.3 Telepsychiatry Industry Opportunities and Challenges
  4. 2.4 Telepsychiatry Industry Restraints
3 Telepsychiatry Market by Company
  1. 3.1 Global Telepsychiatry Company Revenue Ranking in 2025
  2. 3.2 Global Telepsychiatry Revenue by Company (2021-2026)
  3. 3.3 Global Telepsychiatry Company Ranking (2024-2026)
  4. 3.4 Global Telepsychiatry Company Manufacturing Base and Headquarters
  5. 3.5 Global Telepsychiatry Company Product Type and Application
  6. 3.6 Global Telepsychiatry Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Telepsychiatry Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Telepsychiatry Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Telepsychiatry Market by Type
  1. 4.1 Telepsychiatry Type Introduction
  2. 4.1.1 Routine Telepsychiatry
  3. 4.1.2 Forensic Telepsychiatry
  4. 4.1.3 Crisis Telepsychiatry
  5. 4.1.4 In-Home Telepsychiatry
  6. 4.2 Global Telepsychiatry Sales Value by Type
  7. 4.2.1 Global Telepsychiatry Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Telepsychiatry Sales Value by Type (2021-2032)
  9. 4.2.3 Global Telepsychiatry Sales Value Share by Type (2021-2032)
5 Telepsychiatry Market by Application
  1. 5.1 Telepsychiatry Application Introduction
  2. 5.1.1 Adults
  3. 5.1.2 Teenagers
  4. 5.1.3 Geriatric Populations
  5. 5.2 Global Telepsychiatry Sales Value by Application
  6. 5.2.1 Global Telepsychiatry Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Telepsychiatry Sales Value by Application (2021-2032)
  8. 5.2.3 Global Telepsychiatry Sales Value Share by Application (2021-2032)
6 Telepsychiatry Regional Value Analysis
  1. 6.1 Global Telepsychiatry Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Telepsychiatry Sales Value by Region (2021-2032)
  3. 6.2.1 Global Telepsychiatry Sales Value by Region: 2021-2026
  4. 6.2.2 Global Telepsychiatry Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Telepsychiatry Sales Value (2021-2032)
  7. 6.3.2 North America Telepsychiatry Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Telepsychiatry Sales Value (2021-2032)
  10. 6.4.2 Europe Telepsychiatry Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Telepsychiatry Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Telepsychiatry Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Telepsychiatry Sales Value (2021-2032)
  16. 6.6.2 South America Telepsychiatry Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Telepsychiatry Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Telepsychiatry Sales Value Share by Country, 2025 VS 2032
7 Telepsychiatry Country-level Value Analysis
  1. 7.1 Global Telepsychiatry Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Telepsychiatry Sales Value by Country (2021-2032)
  3. 7.2.1 Global Telepsychiatry Sales Value by Country (2021-2026)
  4. 7.2.2 Global Telepsychiatry Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Telepsychiatry Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Telepsychiatry Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Telepsychiatry Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Telepsychiatry Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Telepsychiatry Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Telepsychiatry Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Telepsychiatry Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Telepsychiatry Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Telepsychiatry Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Telepsychiatry Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Telepsychiatry Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Telepsychiatry Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Telepsychiatry Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Telepsychiatry Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Telepsychiatry Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Telepsychiatry Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Telepsychiatry Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Telepsychiatry Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Telepsychiatry Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Telepsychiatry Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Telepsychiatry Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Telepsychiatry Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Telepsychiatry Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Telepsychiatry Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Telepsychiatry Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Telepsychiatry Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Telepsychiatry Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Telepsychiatry Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Telepsychiatry Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Telepsychiatry Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Telepsychiatry Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Telepsychiatry Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Telepsychiatry Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Telepsychiatry Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Telepsychiatry Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Telepsychiatry Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Telepsychiatry Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Telepsychiatry Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Telepsychiatry Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Telepsychiatry Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Telepsychiatry Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Telepsychiatry Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Telepsychiatry Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Telepsychiatry Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Telepsychiatry Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Telepsychiatry Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Telepsychiatry Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Telepsychiatry Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Telepsychiatry Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Telepsychiatry Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Telepsychiatry Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Telepsychiatry Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Telepsychiatry Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Telepsychiatry Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Telepsychiatry Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Telepsychiatry Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Telepsychiatry Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Telepsychiatry Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Telepsychiatry Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Telepsychiatry Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Telepsychiatry Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Telepsychiatry Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Telepsychiatry Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Telepsychiatry Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Telepsychiatry Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Telepsychiatry Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Telepsychiatry Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Telepsychiatry Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Telepsychiatry Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Telepsychiatry Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Telepsychiatry Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Telepsychiatry Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Telepsychiatry Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Telepsychiatry Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Telepsychiatry Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Telepsychiatry Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Telepsychiatry Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Telepsychiatry Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Telepsychiatry Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Telepsychiatry Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Telepsychiatry Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Telepsychiatry Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Telepsychiatry Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Telepsychiatry Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 InSight Telepsychiatry
  2. 8.1.1 InSight Telepsychiatry Company Information
  3. 8.1.2 InSight Telepsychiatry Business Overview
  4. 8.1.3 InSight Telepsychiatry Telepsychiatry Revenue and Gross Margin (2021-2026)
  5. 8.1.4 InSight Telepsychiatry Telepsychiatry Product Portfolio
  6. 8.1.5 InSight Telepsychiatry Recent Developments
  7. 8.2 American Telepsychiatrists
  8. 8.2.1 American Telepsychiatrists Company Information
  9. 8.2.2 American Telepsychiatrists Business Overview
  10. 8.2.3 American Telepsychiatrists Telepsychiatry Revenue and Gross Margin (2021-2026)
  11. 8.2.4 American Telepsychiatrists Telepsychiatry Product Portfolio
  12. 8.2.5 American Telepsychiatrists Recent Developments
  13. 8.3 Iris Telehealth
  14. 8.3.1 Iris Telehealth Company Information
  15. 8.3.2 Iris Telehealth Business Overview
  16. 8.3.3 Iris Telehealth Telepsychiatry Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Iris Telehealth Telepsychiatry Product Portfolio
  18. 8.3.5 Iris Telehealth Recent Developments
  19. 8.4 JSA Health
  20. 8.4.1 JSA Health Company Information
  21. 8.4.2 JSA Health Business Overview
  22. 8.4.3 JSA Health Telepsychiatry Revenue and Gross Margin (2021-2026)
  23. 8.4.4 JSA Health Telepsychiatry Product Portfolio
  24. 8.4.5 JSA Health Recent Developments
  25. 8.5 Advanced Telemed Services
  26. 8.5.1 Advanced Telemed Services Company Information
  27. 8.5.2 Advanced Telemed Services Business Overview
  28. 8.5.3 Advanced Telemed Services Telepsychiatry Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Advanced Telemed Services Telepsychiatry Product Portfolio
  30. 8.5.5 Advanced Telemed Services Recent Developments
  31. 8.6 FasPsych
  32. 8.6.1 FasPsych Company Information
  33. 8.6.2 FasPsych Business Overview
  34. 8.6.3 FasPsych Telepsychiatry Revenue and Gross Margin (2021-2026)
  35. 8.6.4 FasPsych Telepsychiatry Product Portfolio
  36. 8.6.5 FasPsych Recent Developments
  37. 8.7 Genoa
  38. 8.7.1 Genoa Company Information
  39. 8.7.2 Genoa Business Overview
  40. 8.7.3 Genoa Telepsychiatry Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Genoa Telepsychiatry Product Portfolio
  42. 8.7.5 Genoa Recent Developments
  43. 8.8 Encounter Telehealth
  44. 8.8.1 Encounter Telehealth Company Information
  45. 8.8.2 Encounter Telehealth Business Overview
  46. 8.8.3 Encounter Telehealth Telepsychiatry Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Encounter Telehealth Telepsychiatry Product Portfolio
  48. 8.8.5 Encounter Telehealth Recent Developments
  49. 8.9 Arcadian Telepsychiatry
  50. 8.9.1 Arcadian Telepsychiatry Company Information
  51. 8.9.2 Arcadian Telepsychiatry Business Overview
  52. 8.9.3 Arcadian Telepsychiatry Telepsychiatry Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Arcadian Telepsychiatry Telepsychiatry Product Portfolio
  54. 8.9.5 Arcadian Telepsychiatry Recent Developments
  55. 8.10 InnovaTel
  56. 8.10.1 InnovaTel Company Information
  57. 8.10.2 InnovaTel Business Overview
  58. 8.10.3 InnovaTel Telepsychiatry Revenue and Gross Margin (2021-2026)
  59. 8.10.4 InnovaTel Telepsychiatry Product Portfolio
  60. 8.10.5 InnovaTel Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research